Proton Pump Inhibitors Market

Proton Pump Inhibitors Market contains market size and forecasts of Proton Pump Inhibitors (PPIs) in global, including the following market information:

• Global Proton Pump Inhibitors (PPIs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Proton Pump Inhibitors (PPIs) Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Proton Pump Inhibitors (PPIs) companies in 2021 (%)

The global Proton Pump Inhibitors (PPIs) market was valued at 12540 million in 2021 and is projected to reach US$ 10130 million by 2028, at a CAGR of -3.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pantoprazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Proton Pump Inhibitors (PPIs) include AstraZeneca, Pfizer, Janssen, Eisai, Eli Lilly, Cadila Pharmaceuticals, Santarus, Wyeth and Changzhou Siyao Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Proton Pump Inhibitors (PPIs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Proton Pump Inhibitors (PPIs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Proton Pump Inhibitors (PPIs) Market Segment Percentages, by Type, 2021 (%)

• Pantoprazole
• Omeprazole
• Lansoprazole
• Esomeprazole
• Rabeprazole
• Others

Global Proton Pump Inhibitors (PPIs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Proton Pump Inhibitors (PPIs) Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Proton Pump Inhibitors (PPIs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Proton Pump Inhibitors (PPIs) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Proton Pump Inhibitors (PPIs) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Proton Pump Inhibitors (PPIs) revenues share in global market, 2021 (%)
• Key companies Proton Pump Inhibitors (PPIs) sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Proton Pump Inhibitors (PPIs) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Pfizer
• Janssen
• Eisai
• Eli Lilly
• Cadila Pharmaceuticals
• Santarus
• Wyeth
• Changzhou Siyao Pharmaceuticals
• Yangzhou Pharmaceutical